Fresh analysis reveals that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Findings released in a leading medical journal shows that while obese individuals frequently drop a large proportion of their total mass while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Individuals buying such medications need to be informed of the risk of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to original mass in about a year and a half.
Comparing Therapies
The analysis, which looked at dozens of trials involving thousands of patients, compared the outcomes of these new drugs with older methods.
The team emphasize that individuals who shed pounds through dieting generally experience a less rapid weight regain—around 0.1 kg a month—post-intervention.
Explaining the Rapid Rebound
Nutrition scientists believe the way of the jabs explains the amplified weight return.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication leads to appetite is unsuppressed, making overeating a significant risk."
An Ongoing Issue?
Medical guidelines suggest the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts contend that, due to the significant potential of relapse, the therapy might need to be long-term.
This opinion is reinforced by drug manufacturers, who say that the results "highlight the persistent nature of excess weight," similar to managing diseases like hypertension.
User Testimonies
People who have discontinued the medication report a powerful resurgence of hunger.
"I experienced a trigger activating and I was suddenly ravenous," said an individual.
This difficulty is compounded if patients have not developed sustainable dietary or behavioural changes during therapy.
Widespread Interest
Survey data indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is greater among females than males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are effective agents for weight loss, they are not a permanent solution and long-term success relies on integrated lifestyle changes.
